Wary pharma: AstraZeneca sours on UK

An interview with Lee Jae Myung, South Korea’s president, a year into his role. Though he has stabilised a turbulent polity and overseen a stock market rally, the path ahead may be bumpy. Can India’s cockroach party become a powerful political movement? And celebrating the creato ...  Show more

Millions of people will tune in when the World Cup starts today. But demonstrators in Mexico, which hosts the first match, are using the international spectacle to draw attention to their causes. Commercial enterprises are on the cusp of making money in space: who will tax the he ...  Show more

Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean a ...  Show more

America’s health secretary, RFK Jr, is known for his opposition to vaccines, particularly mRNA jabs, that have the potential to treat a large swathe of diseases. Slashing funding will have long term implications beyond America. Our correspondent visits Britain’s biggest and newes ...  Show more

With China as its new rival, America is reviving old wartime facilities across the Pacific. Our correspondent visits an abandoned airfield that has been given new life. The outlook for climate technology is surprisingly bright. And why the universe of Hello Kitty keeps expanding. ...  Show more

Since Donald Trump announced punishing tariffs on “Liberation Day” last week, stock markets have fallen and governments and businesses scrambled to respond. Our correspondent discusses the impact on the global economy. Do personalised diets really improve gut health (9:16)? And g ...  Show more